Eli Lilly’s Alzheimer’s treatment approved in China

Eli Lilly’s Alzheimer’s treatment approved in China

(Reuters) – China’s medical regulator has approved Eli Lilly (NYSE:LLY)’s treatment for early Alzheimer’s, providing patients with another option after Eisai and Biogen (NASDAQ:BIIB)’s Leqembi received approval in January, the…
CommScope stock surges on debt refinancing deal

CommScope stock surges on debt refinancing deal

Investing.com — Shares of CommScope Holding (NASDAQ:COMM) Company, Inc. (NASDAQ:COMM) soared 30% following the company’s announcement of a comprehensive refinancing plan that addresses its upcoming debt maturities and positions it…